Cargando…
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections
PURPOSE: This study aimed to provide compelling evidence of anti-staphylococcal beta-lactam use for methicillin-susceptible Staphylococcus aureus bloodstream infection (MSSA BSI). MATERIALS AND METHODS: We retrospectively collected data on patients with MSSA BSI who were admitted to two academic ter...
Autores principales: | La, Yeon Ju, Kim, Hye Rim, Oh, Dong Hyun, Ahn, Jin Young, Kim, Yong Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226830/ https://www.ncbi.nlm.nih.gov/pubmed/35748072 http://dx.doi.org/10.3349/ymj.2022.63.7.611 |
Ejemplares similares
-
1827. Comparison of clinical outcomes for glycopeptides and beta-lactams in methicillin-susceptible Staphylococcus aureus bloodstream infections
por: La, Yeon Ju, et al.
Publicado: (2022) -
In Vitro Selection of High-Level Beta-Lactam Resistance in Methicillin-Susceptible Staphylococcus aureus
por: Gostev, Vladimir, et al.
Publicado: (2021) -
Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study
por: Oh, Dong Hyun, et al.
Publicado: (2018) -
Antibiotic Treatment of Vertebral Osteomyelitis caused by Methicillin-Susceptible Staphylococcus aureus: A Focus on the Use of Oral β-lactams
por: Oh, Won Sup, et al.
Publicado: (2019) -
177. Clinical Outcomes of Daptomycin vs. Anti-Staphylococcal β-Lactams in Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bloodstream Infections
por: Agnello, Sydney, et al.
Publicado: (2019)